{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:14:10Z","timestamp":1788563650347,"version":"build-2803163510"},"reference-count":153,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.avsg.2007.12.012","type":"journal-article","created":{"date-parts":[[2008,9,15]],"date-time":"2008-09-15T21:05:48Z","timestamp":1221512748000},"page":"481-491","source":"Crossref","is-referenced-by-count":56,"title":["Does Diabetes Mellitus Play a Role in Restenosis and Patency Rates Following Lower Extremity Peripheral Arterial Revascularization? A Critical Overview"],"prefix":"10.1016","volume":"22","author":[{"given":"Kosmas I.","family":"Paraskevas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryll M.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Pompella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2007.12.012_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejvs.2005.08.015","article-title":"Review of prevalence and outcome of vascular disease in patients with diabetes mellitus","volume":"31","author":"Weiss","year":"2006","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/dmr.5610030206","article-title":"Diabetes and atherosclerosis: an epidemiologic view","volume":"3","author":"Pyorala","year":"1987","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.avsg.2007.12.012_bib3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2337\/diacare.15.9.1141","article-title":"Diabetes mellitus and macrovascular complications. An epidemiological perspective","volume":"15","author":"Donahue","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.avsg.2007.12.012_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2337\/diabetes.38.4.504","article-title":"Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study","volume":"38","author":"Brand","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.avsg.2007.12.012_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.CIR.82.1.27","article-title":"5-year incidence of atherosclerotic renovascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects","volume":"82","author":"Uusitupa","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib6","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2337\/diacare.24.8.1433","article-title":"Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome","volume":"24","author":"Jude","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.avsg.2007.12.012_bib7","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/j.1538-7836.2005.01368.x","article-title":"Medical management of peripheral arterial disease","volume":"3","author":"Bendermacher","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.avsg.2007.12.012_bib8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/S10016-006-9104-1","article-title":"Statins and peripheral arterial disease: potential mechanisms and clinical benefits","volume":"20","author":"Alnaeb","year":"2006","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/107424840501000209","article-title":"Lipid-lowering therapy in patients with peripheral arterial disease","volume":"10","author":"Daskalopoulou","year":"2005","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.avsg.2007.12.012_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1191\/1358863x02vm447ra","article-title":"Pharmacologic treatment for intermittent claudication","volume":"7","author":"Dean","year":"2002","journal-title":"Vasc Med"},{"key":"10.1016\/j.avsg.2007.12.012_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/000331970505600307","article-title":"Risk modification in patients with peripheral arterial disease: a retrospective survey","volume":"56","author":"Youssef","year":"2005","journal-title":"Angiology"},{"key":"10.1016\/j.avsg.2007.12.012_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09537105310001645960","article-title":"The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease","volume":"15","author":"Jagroop","year":"2004","journal-title":"Platelets"},{"key":"10.1016\/j.avsg.2007.12.012_bib13","first-page":"1965","article-title":"Percutaneous interventions for lower extremity peripheral vascular disease","volume":"64","author":"De Sanctis","year":"2001","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.avsg.2007.12.012_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jvs.2006.09.015","article-title":"SMART Study Group. The course of vascular risk factors and the occurrence of vascular events in patients with symptomatic peripheral arterial disease","volume":"45","author":"Goessens","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/j.tvir.2006.04.004","article-title":"Surgical management of critical limb ischemia","volume":"8","author":"Ballard","year":"2005","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2007.12.012_bib16","first-page":"1971","article-title":"Peripheral vascular disease: diagnosis and management","volume":"73","author":"Sontheimer","year":"2006","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.avsg.2007.12.012_bib17","first-page":"747","article-title":"Peripheral vascular diseases: an update on endovascular therapy","volume":"57","author":"Henry","year":"2005","journal-title":"Indian Heart J"},{"key":"10.1016\/j.avsg.2007.12.012_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/10623320500476617","article-title":"Endothelial progenitor cells and their potential clinical applications in peripheral arterial disease","volume":"12","author":"Alobaid","year":"2005","journal-title":"Endothelium"},{"key":"10.1016\/j.avsg.2007.12.012_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1586\/14779072.3.3.521","article-title":"Angiogenic therapy for coronary artery and peripheral arterial disease","volume":"3","author":"Hughes","year":"2005","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.avsg.2007.12.012_bib20","doi-asserted-by":"crossref","DOI":"10.2174\/157016108783955356","article-title":"Angiogenesis: a promising treatment option for peripheral arterial disease","author":"Paraskevas","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.avsg.2007.12.012_bib21","first-page":"555","article-title":"Predicting the risk of restenosis after angioplasty in patients with peripheral arterial disease","volume":"47","author":"Roller","year":"2001","journal-title":"Clin Lab"},{"key":"10.1016\/j.avsg.2007.12.012_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1078-5884(96)80185-7","article-title":"Smoking and plasma fibrinogen, lipoprotein (a) and serotonin are markers for postoperative infrainguinal graft stenosis","volume":"11","author":"Cheshire","year":"1996","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1051-0443(95)71198-8","article-title":"Multicenter trial of the wallstent in the iliac and femoral arteries","volume":"6","author":"Martin","year":"1995","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2007.12.012_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1583\/04-1359.1","article-title":"Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries","volume":"12","author":"Sabeti","year":"2005","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2007.12.012_bib25","first-page":"1043","article-title":"Self-expanding nitinol stents in canine vertebral arteries: hemodynamics and tissue response","volume":"16","author":"Wakhloo","year":"1995","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.avsg.2007.12.012_bib26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ejvs.2004.06.010","article-title":"Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoro-popliteal artery","volume":"28","author":"Laxdal","year":"2004","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1067\/mva.2001.112300","article-title":"Limb salvage after successful pedal bypass grafting is associated with improved long-term survival","volume":"33","author":"Kalra","year":"2001","journal-title":"J Vasc Surg"},{"issue":"3 Suppl","key":"10.1016\/j.avsg.2007.12.012_bib28","first-page":"6","article-title":"Advances in diabetes for the millennium: diabetes and the endothelium","volume":"6","author":"Dandona","year":"2004","journal-title":"MedGenMed"},{"key":"10.1016\/j.avsg.2007.12.012_bib29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1172\/JCI117433","article-title":"Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release","volume":"94","author":"Steinberg","year":"1994","journal-title":"J Clin Invest"},{"issue":"Suppl. 1","key":"10.1016\/j.avsg.2007.12.012_bib30","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1177\/1358836X0501000106","article-title":"Insulin resistance: a potential role of the endogenous nitric oxide synthase inhibitor ADMA","volume":"10","author":"Sydow","year":"2005","journal-title":"Vasc Med"},{"key":"10.1016\/j.avsg.2007.12.012_bib31","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1152\/ajpendo.2000.279.1.E11","article-title":"Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression","volume":"279","author":"Ding","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.avsg.2007.12.012_bib32","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1161\/01.CIR.88.6.2510","article-title":"Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus","volume":"88","author":"Johnstone","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0735-1097(95)00522-6","article-title":"Impaired nitric oxide\u2013mediated vasodilation in patients with non-insulin-dependent diabetes mellitus","volume":"27","author":"Williams","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2007.12.012_bib34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0026-0495(83)90130-0","article-title":"Effect of nonesterified fatty acids on the stability of prostacyclin activity","volume":"32","author":"Mikhailidis","year":"1983","journal-title":"Metabolism"},{"key":"10.1016\/j.avsg.2007.12.012_bib35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0140-6736(83)91883-4","article-title":"Prostacyclin release in vivo","volume":"1","author":"Dandona","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2007.12.012_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2337\/diabetes.32.3.217","article-title":"Simulating the diabetic environment modifies in vitro prostacyclin synthesis","volume":"32","author":"Jeremy","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.avsg.2007.12.012_bib37","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2337\/diabetes.49.7.1239","article-title":"Induction of endothelin-1 expression by glucose: an effect of protein kinase C\u00a0activation","volume":"49","author":"Park","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.avsg.2007.12.012_bib38","first-page":"77","article-title":"Plasma endothelin-1 concentrations in non-insulin-dependent diabetes mellitus and nondiabetic patients with chronic arterial obstructive disease of the lower limbs","volume":"18","author":"Jagroop","year":"1999","journal-title":"Int Angiol"},{"key":"10.1016\/j.avsg.2007.12.012_bib39","first-page":"97","article-title":"Plasma endothelin-1 concentrations in non-insulin-dependent diabetes mellitus and nondiabetic patients with chronic arterial obstructive disease of the lower limbs","volume":"17","author":"Mangiafico","year":"1998","journal-title":"Int Angiol"},{"key":"10.1016\/j.avsg.2007.12.012_bib40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/000331970205300305","article-title":"Carotid atherosclerosis in type 2 diabetes mellitus: potential role of endothelin-1, lipoperoxides, and prostacyclin","volume":"53","author":"Kalogeropoulou","year":"2002","journal-title":"Angiology"},{"key":"10.1016\/j.avsg.2007.12.012_bib41","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1161\/01.CIR.0000065222.34933.FC","article-title":"Hoorn Study. Arterial stiffness increased with deteriorating glucose tolerance status: the Hoorn Study","volume":"107","author":"Henry","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib42","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.ATV.0000160548.78317.29","article-title":"Mechanisms, pathophysiology, and therapy of arterial stiffness","volume":"25","author":"Zieman","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2007.12.012_bib43","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.0000069826.36125.B4","article-title":"Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases","volume":"107","author":"Safar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib44","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/01.CIR.0000033824.02722.F7","article-title":"Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?","volume":"106","author":"Cruickshank","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib45","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","article-title":"Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients","volume":"37","author":"Laurent","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.avsg.2007.12.012_bib46","first-page":"517","article-title":"The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests","volume":"35","author":"Koltai","year":"2006","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.avsg.2007.12.012_bib47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/ejvs.2002.1794","article-title":"Increased platelet aggregation and activation in peripheral arterial disease","volume":"25","author":"Robless","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10016-001-0159-8","article-title":"The role of platelets in peripheral arterial disease: therapeutic implications","volume":"16","author":"Matsagas","year":"2002","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-4165(94)90019-1","article-title":"Isolation of nitric oxide synthase from human platelets","volume":"1200","author":"Muruganandam","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.avsg.2007.12.012_bib50","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(87)91481-4","article-title":"Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium","volume":"2","author":"Radomski","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2007.12.012_bib51","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1053\/euhj.2001.3116","article-title":"D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease","volume":"23","author":"Komarov","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2007.12.012_bib52","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.0007-1323.2001.01774.x","article-title":"Systematic review of\u00a0antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease","volume":"88","author":"Robless","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11892-002-0019-0","article-title":"Endothelium, inflammation, and diabetes","volume":"2","author":"Dandona","year":"2002","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.avsg.2007.12.012_bib54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/187152506776369908","article-title":"Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapy","volume":"4","author":"Anfossi","year":"2006","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.avsg.2007.12.012_bib55","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2174\/138161206776843322","article-title":"The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management","volume":"12","author":"Lim","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.avsg.2007.12.012_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/157016106777698432","article-title":"Dyslipidaemia, hypercoagulability and the metabolic syndrome","volume":"4","author":"Kakafika","year":"2006","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.avsg.2007.12.012_bib57","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2337\/diabetes.43.1.104","article-title":"Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients","volume":"43","author":"McGill","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.avsg.2007.12.012_bib58","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2337\/db05-1543","article-title":"Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans","volume":"55","author":"Stegenga","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.avsg.2007.12.012_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s005920170016","article-title":"Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type I in the rat","volume":"38","author":"Pandolfi","year":"2001","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.avsg.2007.12.012_bib60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-2002-23098","article-title":"Coagulation and fibrinolysis in diabetes","volume":"2","author":"Banga","year":"2002","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.avsg.2007.12.012_bib61","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/01.ATV.18.8.1199","article-title":"Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus","volume":"18","author":"Nilsson","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2007.12.012_bib62","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/01.ATV.19.4.972","article-title":"C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?","volume":"19","author":"Yudkin","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2007.12.012_bib63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib64","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/meta.2002.32804","article-title":"Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes","volume":"51","author":"Temelkova-Kurktschiev","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.avsg.2007.12.012_bib65","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/eurheartj\/ehl441","article-title":"Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study","volume":"28","author":"Tzoulaki","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2007.12.012_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jvs.2006.02.048","article-title":"Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity","volume":"44","author":"Brevetti","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib67","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/gerona\/61.4.374","article-title":"Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer","volume":"61","author":"McDermott","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.avsg.2007.12.012_bib68","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00270-005-0159-0","article-title":"The role of coagulation and inflammation after angioplasty in patients with peripheral arterial disease","volume":"29","author":"Wahlgren","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2007.12.012_bib69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1527-3466.2006.00033.x","article-title":"C-reactive protein (CRP)\u2013lowering agents","volume":"24","author":"Prasad","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.avsg.2007.12.012_bib70","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI119229","article-title":"Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products","volume":"99","author":"Rumble","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.avsg.2007.12.012_bib71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/mvre.1998.2107","article-title":"Cellular mechanisms of diabetic vascular hypertrophy","volume":"57","author":"Vranes","year":"1999","journal-title":"Microvasc Res"},{"key":"10.1016\/j.avsg.2007.12.012_bib72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/01.RES.86.2.158","article-title":"Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes","volume":"86","author":"Gilbert","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2007.12.012_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2840-5-3","article-title":"Type-2 diabetes\u2013induced changes in vascular extracellular matrix gene expression: relation to vessel size","volume":"5","author":"Song","year":"2006","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.avsg.2007.12.012_bib74","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.2337\/diabetes.54.9.2638","article-title":"Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1","volume":"54","author":"Harris","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.avsg.2007.12.012_bib75","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1053\/ejvs.1998.0806","article-title":"Influence of diabetes on revascularization procedures of the aorta and lower limb arteries: early results","volume":"17","author":"Melliere","year":"1999","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2 Suppl.","key":"10.1016\/j.avsg.2007.12.012_bib76","first-page":"I70","article-title":"Femoropopliteal angioplasty. Factors influencing long-term success","volume":"83","author":"Capek","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib77","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/ejvs.2002.1899","article-title":"Subintimal angioplasty as treatment of femoropopliteal artery occlusions","volume":"25","author":"Laxdal","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/ejvs.2002.1849","article-title":"Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre comparative analysis","volume":"25","author":"Wolfle","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib79","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/bjs.1800820925","article-title":"Percutaneous transluminal angioplasty for lower-limb critical ischemia","volume":"82","author":"London","year":"1995","journal-title":"Br J Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib80","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ejvs.2005.02.035","article-title":"Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003","volume":"29","author":"Faglia","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib81","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/bjs.1800830722","article-title":"Changes in the management of critical limb ischaemia","volume":"83","author":"Varty","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib82","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejvs.2004.03.023","article-title":"Percutaneous transluminal angioplasty for critical limb ischaemia in octogenarians and nonagenarians","volume":"28","author":"Salas","year":"2004","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib83","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF02578675","article-title":"Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection","volume":"13","author":"Bolia","year":"1990","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2007.12.012_bib84","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0950-821X(05)80450-5","article-title":"Subintimal angioplasty of femoropopliteal artery occlusions: the long-term results","volume":"8","author":"London","year":"1994","journal-title":"Eur J Vasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib85","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/ejvs.2000.1200","article-title":"Subintimal angioplasty of tibial vessel occlusions in the treatment of critical limb ischaemia: mid-term results","volume":"20","author":"Vraux","year":"2000","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib86","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1464-5491.1995.tb00537.x","article-title":"Comparative analysis of patency, limb salvage and survival in diabetic and non-diabetic patients undergoing infrainguinal bypass surgery","volume":"12","author":"Karacagil","year":"1995","journal-title":"Diabet Med"},{"key":"10.1016\/j.avsg.2007.12.012_bib87","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1055\/s-2008-1063732","article-title":"Long-term results after infrainguinal arterial reconstruction in patients with type 2 diabetes mellitus and without diabetes mellitus","volume":"116","author":"Stirnemann","year":"1991","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.avsg.2007.12.012_bib88","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1078-5884(97)80066-4","article-title":"Femorotibial reconstructions for chronic critical leg ischaemia: influence on outcome by diabetes, gender and age","volume":"13","author":"Luther","year":"1997","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib89","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0741-5214(97)70220-9","article-title":"Predictors of long-term patient survival after in situ vein leg bypass","volume":"25","author":"Kalman","year":"1997","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib90","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0741-5214(90)90262-9","article-title":"Present status of reversed vein bypass grafting: five-year results of a modern series","volume":"11","author":"Taylor","year":"1990","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib91","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/(SICI)1096-9136(199608)13:8<726::AID-DIA145>3.0.CO;2-P","article-title":"The management and outcome of critical limb ischaemia in diabetic patients: results of a national survey. Audit Committee of the Vascular Surgical Society of Great Britain and Ireland","volume":"13","author":"da Silva","year":"1996","journal-title":"Diabet Med"},{"key":"10.1016\/j.avsg.2007.12.012_bib92","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1464-5491.1992.tb01821.x","article-title":"The effect of diabetes mellitus on the outcome of angioplasty for lower limb ischaemia","volume":"9","author":"Davies","year":"1992","journal-title":"Diabet Med"},{"key":"10.1016\/j.avsg.2007.12.012_bib93","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/archsurg.135.4.452","article-title":"Lower extremity revascularization in diabetes: late observations","volume":"135","author":"Akbari","year":"2000","journal-title":"Arch Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib94","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1051-0443(07)61332-3","article-title":"Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results","volume":"11","author":"Soder","year":"2000","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2007.12.012_bib95","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/ejvs.2002.1735","article-title":"Pedal arterial bypass for limb salvage in patients with diabetes mellitus","volume":"24","author":"Dorweiler","year":"2002","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib96","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1583\/03-1159.1","article-title":"Clinical outcome of primary infrainguinal subintimal angioplasty in diabetic patients with critical lower limb ischemia","volume":"11","author":"Lazaris","year":"2004","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2007.12.012_bib97","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/ejvs.2002.1615","article-title":"The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischaemia","volume":"23","author":"Nasr","year":"2002","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib98","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejvs.2005.12.019","article-title":"The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischaemia","volume":"32","author":"Awad","year":"2006","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib99","first-page":"331","article-title":"Results of vein graft reconstruction of the lower extremity in diabetic and nondiabetic patients","volume":"171","author":"Rosenblatt","year":"1990","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.avsg.2007.12.012_bib100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1056-8727(97)00111-6","article-title":"Impact of diabetes mellitus on infrainguinal bypass grafting","volume":"12","author":"Gahtan","year":"1998","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.avsg.2007.12.012_bib101","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2214\/ajr.172.5.10227512","article-title":"Diabetic versus nondiabetic limb-threatening ischemia: outcome of percutaneous iliac intervention","volume":"172","author":"Spence","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.avsg.2007.12.012_bib102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.RVI.0000136030.26074.33","article-title":"Insulin, C-peptide, and restenosis after femoral artery balloon angioplasty in type II diabetic and nondiabetic patients","volume":"16","author":"Maca","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2007.12.012_bib103","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1148\/radiol.2272020137","article-title":"Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level","volume":"227","author":"Schillinger","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.avsg.2007.12.012_bib104","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/diacare.27.2.468","article-title":"Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes","volume":"27","author":"Sommeijer","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.avsg.2007.12.012_bib105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0021-9150(02)00316-7","article-title":"DALI-Study Group. Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus","volume":"166","author":"van der Ree","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.avsg.2007.12.012_bib106","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1056-8727(02)00184-8","article-title":"Simvastatin reduces plasma concentration of high-sensitivity C-reactive protein in type 2 diabetic patients with hyperlipidemia","volume":"16","author":"Lee","year":"2002","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.avsg.2007.12.012_bib107","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1517\/14728222.10.6.851","article-title":"Non-low-density lipoprotein cholesterol\u2013associated actions of ezetimibe: an overview","volume":"10","author":"Gazi","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.avsg.2007.12.012_bib108","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5551\/jat.12.205","article-title":"Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus","volume":"12","author":"Shinohara","year":"2005","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.avsg.2007.12.012_bib109","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/000331970405500108","article-title":"The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease","volume":"55","author":"Youssef","year":"2004","journal-title":"Angiology"},{"key":"10.1016\/j.avsg.2007.12.012_bib110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/jcp.2003.012989","article-title":"The effect of statins versus untreated dyslipidemia in patients with coronary heart disease. A subgroup analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study","volume":"57","author":"Athyros","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.avsg.2007.12.012_bib111","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2007.12.012_bib112","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.0000090686.57897.F5","article-title":"Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease","volume":"108","author":"Mohler","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib113","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2005.10.052","article-title":"Statin use and functional decline in patients with and without peripheral arterial disease","volume":"47","author":"Giri","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2007.12.012_bib114","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.295.5.547","article-title":"Medical treatment of peripheral arterial disease","volume":"295","author":"Hankey","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.avsg.2007.12.012_bib115","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ncpcardio0660","article-title":"Established and evolving medical therapies for claudication in patients with peripheral arterial disease","volume":"3","author":"Regensteiner","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.avsg.2007.12.012_bib116","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02693937","article-title":"Statin therapy in cardiovascular diseases other than atherosclerosis","volume":"9","author":"Beaudry","year":"2007","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.avsg.2007.12.012_bib117","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/0929867053363009","article-title":"Peripheral arterial disease: a missed opportunity to administer statins so as to reduce cardiac morbidity and mortality","volume":"12","author":"Daskalopoulou","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.avsg.2007.12.012_bib118","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejvs.2006.11.020","article-title":"The rationale for using HMG-CoA reductase inhibitors (\u201cstatins\u201d) in peripheral arterial disease","volume":"33","author":"Erez","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib119","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1538574406291835","article-title":"Optimal medical management of peripheral arterial disease","volume":"40","author":"Rice","year":"2006","journal-title":"Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib120","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ehj.2004.02.012","article-title":"Statin therapy improves cardiovascular outcome of patients with peripheral artery disease","volume":"25","author":"Schillinger","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2007.12.012_bib121","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2007.12.012_bib122","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1503\/cmaj.1031965","article-title":"Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis","volume":"171","author":"Brown","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.avsg.2007.12.012_bib123","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jvs.2003.08.030","article-title":"Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality","volume":"39","author":"Henke","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib124","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(02)07751-6","article-title":"Overcoming restenosis with sirolimus: from alphabet soup to clinical reality","volume":"359","author":"Poon","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2007.12.012_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002071.pub2","article-title":"Antiplatelet and anticoagulant drugs for prevention of restenosis\/reocclusion following peripheral endovascular treatment","volume":"1","author":"Dorffler-Melly","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.avsg.2007.12.012_bib126","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/000331970105201002","article-title":"Potential use of a low-molecular-weight heparin to prevent restenosis in patients with extensive wall damage following peripheral angioplasty","volume":"52","author":"Schweizer","year":"2001","journal-title":"Angiology"},{"key":"10.1016\/j.avsg.2007.12.012_bib127","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1053\/ejvs.1999.1034","article-title":"Antiplatelet therapy and other interventions after revascularization procedures in patients with peripheral arterial disease: a meta-analysis","volume":"19","author":"Girolami","year":"2000","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib128","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.CIR.0000028335.31300.DA","article-title":"Results of Prevention of Restenosis with Tranilast and Its Outcomes (PRESTO) trial","volume":"106","author":"Holmes","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0735-1097(01)01741-7","volume":"39","author":"Kutryk","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2007.12.012_bib130","first-page":"326","article-title":"Anti-restenosis trials","volume":"2","author":"De Feyter","year":"2000","journal-title":"Curr Interv Cardiol Rep"},{"key":"10.1016\/j.avsg.2007.12.012_bib131","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1161\/01.CIR.99.16.2164","article-title":"Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle","volume":"99","author":"Gallo","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib132","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/hc3601.093987","article-title":"Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model","volume":"104","author":"Suzuki","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib133","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.CIR.104.8.852","article-title":"Bench to bedside: the development of rapamycin and its application to stent restenosis","volume":"104","author":"Marx","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib134","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/01.CIR.0000029746.10018.36","article-title":"Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results","volume":"106","author":"Duda","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib135","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1583\/05-1704.1","article-title":"Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results form the SIROCCO trial","volume":"13","author":"Duda","year":"2006","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2007.12.012_bib136","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1507\/endocrj.53.45","article-title":"Strict glycemic control ameliorates the increase of carotid IMT in patients with type 2 diabetes","volume":"53","author":"Kawasumi","year":"2006","journal-title":"Endocr J"},{"key":"10.1016\/j.avsg.2007.12.012_bib137","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1161\/CIRCULATIONAHA.104.502179","article-title":"External beam radiation to prevent restenosis after superficial femoral artery balloon angioplasty","volume":"111","author":"Therasse","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib138","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2004.09.010","article-title":"External beam radiation therapy reduces the rate of re-stenosis in patients treated with femoral stenting: results of a randomised study","volume":"74","author":"Zabakis","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.avsg.2007.12.012_bib139","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1583\/1545-1550(2003)010<0304:EBAPTA>2.0.CO;2","article-title":"Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions","volume":"10","author":"Zehnder","year":"2003","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2007.12.012_bib140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/ejvs.2002.1742","article-title":"Intravascular brachytherapy: a systematic review of its role in reducing restenosis after endovascular treatment in peripheral arterial disease","volume":"24","author":"Hansrani","year":"2002","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib141","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0360-3016(96)00412-9","article-title":"Management of peripheral vascular disease: innovative approaches using radiation therapy","volume":"36","author":"Nori","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.avsg.2007.12.012_bib142","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s102380300004","article-title":"Effects of cilostazol on serum lipid concentrations and plasma fatty acid composition in type 2 diabetic patients with peripheral vascular disease","volume":"2","author":"Nakamura","year":"2003","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.avsg.2007.12.012_bib143","first-page":"322","article-title":"Effects of the anti-platelet agent cilostazol on peripheral vascular disease in patients with diabetes mellitus","volume":"42","author":"Uchikawa","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.avsg.2007.12.012_bib144","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003748.pub2","article-title":"Cilostazol for peripheral arterial disease","volume":"1","author":"Robless","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.avsg.2007.12.012_bib145","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/CIRCULATIONAHA.104.530097","article-title":"Cilostazol for Restenosis Trial (CREST) Investigators: Coronary stent restenosis in patients treated with cilostazol","volume":"112","author":"Douglas","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2007.12.012_bib146","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ejvs.2006.03.009","article-title":"Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery?","volume":"32","author":"Paraskevas","year":"2006","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib147","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/vhrm.2007.3.2.229","article-title":"Epidemiology, classification, and modifiable risk factors of peripheral arterial disease","volume":"3","author":"Shammas","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.avsg.2007.12.012_bib148","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/14656566.8.7.901","article-title":"The role of established and emerging risk factors of peripheral arterial disease","volume":"8","author":"Fatourou","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.avsg.2007.12.012_bib149","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.avsg.2007.01.008","article-title":"Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation","volume":"21","author":"Bianchi","year":"2007","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib150","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11606-007-0162-z","article-title":"Mortality in peripheral arterial disease: a comparison of patients managed by vascular specialists and general practitioners","volume":"22","author":"Brevetti","year":"2007","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.avsg.2007.12.012_bib151","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1583\/03-1165.1","article-title":"Long-term outcome of infrainguinal percutaneous transluminal angioplasty","volume":"11","author":"Wahlgren","year":"2004","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.avsg.2007.12.012_bib152","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jvs.2004.11.041","article-title":"The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience","volume":"41","author":"Kudo","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2007.12.012_bib153","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ejvs.2006.07.016","article-title":"Factors affecting patency of subintimal infrainguinal angioplasty in patients with critical lower limb ischemia","volume":"32","author":"Lazaris","year":"2006","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509608000241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509608000241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T01:02:25Z","timestamp":1557795745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509608000241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":153,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0890509608000241"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2007.12.012","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}